697 - Risk of non-melanoma skin cancer in patients with moderate-to-severe atopic dermatitis: a United States population-based study using claims dataatopic dermatitisclaims analysismalignancyreal-worldINTRODUCTION/BACKGROUND. Patients with atopic dermatitis (AD) may be at an ...
Systemic therapies are commonly used for patients with uncontrolled moderate-to-severe atopic dermatitis (AD) and impaired quality of life (QoL). However, real-world treatment patterns and unmet needs of adults with moderate-to-severe AD receiving systemic therapies are poorly quantified. Objective T...